Roche’s Kadcyla helped people with advanced HER2-positive breast cancer live longer without their disease worsening in new phase III study
28 September 2013 | By Roche
Kadcyla nearly doubled the time that patients lived without their disease worsening compared with treatment of physician’s choice...